Literature DB >> 22647872

Prevention and management of ovarian hyperstimulation syndrome.

Chin-Der Chen1, Shee-Uan Chen, Yu-Shih Yang.   

Abstract

Ovarian hyperstimulation syndrome is a relatively common complication of ovarian stimulation and can be life-threatening. The pathophysiology of ovarian hyperstimulation syndrome is characterised by increased capillary permeability, leading to leakage of fluid from the vascular compartment, with third space fluid accumulation and intravascular dehydration. The combined use of a gonadotrophin-releasing hormone antagonist protocol with gonadotrophin-releasing hormone agonist triggering and oocyte and embryo freezing has considerable promise in preventing ovarian hyperstimulation syndrome. Women with severe ovarian hyperstimulation syndrome require hospitalisation for more careful monitoring and treatment. Transvaginal paracentesis can be used as an outpatient treatment to prevent the need for hospitalisation. The inhibition of vascular permeability seems to be a novel therapeutic approach to preventing and treating ovarian hyperstimulation syndrome.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22647872     DOI: 10.1016/j.bpobgyn.2012.04.004

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  6 in total

1.  Comparison of albumin and cabergoline in the prevention of ovarian hyperstimulation syndrome: A clinical trial study.

Authors:  Aalie Torabizadeh; Fatemeh Vahidroodsari; Zakieh Ghorbanpour
Journal:  Iran J Reprod Med       Date:  2013-10

2.  Attenuated AMH signaling pathway plays an important role in the pathogenesis of ovarian hyperstimulation syndrome.

Authors:  Lan Wang; Hemei Li; Jihui Ai; Jing Yue; Zhou Li; Hanwang Zhang; Yiqing Zhao
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

3.  Early stop of progesterone supplementation after confirmation of pregnancy in IVF/ICSI fresh embryo transfer cycles of poor responders does not affect pregnancy outcome.

Authors:  Song-Po Pan; Kuang-Han Chao; Chu-Chun Huang; Ming-Yih Wu; Mei-Jou Chen; Chin-Hao Chang; Jehn-Hsiahn Yang; Yu-Shih Yang; Shee-Uan Chen
Journal:  PLoS One       Date:  2018-08-09       Impact factor: 3.240

4.  Artificial colloids versus human albumin for the treatment of ovarian hyperstimulation syndrome: A retrospective cohort study.

Authors:  Tetsuji Minami; Hayato Yamana; Mph Ph D; Daisuke Shigemi; Hiroki Matsui Mph; Kiyohide Fushimi; Hideo Yasunaga
Journal:  Int J Reprod Biomed       Date:  2019-11-07

5.  Follicular aspiration versus coasting for ovarian hyper-stimulation syndrome prevention.

Authors:  Nayla J Bushaqer; Nawal M Dayoub; Khalsa K AlHattali; Hisham A Ayyoub; Samaher S AlFaraj; Samar N Hassan
Journal:  Saudi Med J       Date:  2018-03       Impact factor: 1.484

Review 6.  Ovarian Hyperstimulation Syndrome: A Narrative Review of Its Pathophysiology, Risk Factors, Prevention, Classification, and Management.

Authors:  Bahia Namavar Jahromi; Mohammad Ebrahim Parsanezhad; Zahra Shomali; Pardis Bakhshai; Mahshid Alborzi; Najmeh Moin Vaziri; Zahra Anvar
Journal:  Iran J Med Sci       Date:  2018-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.